News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Raul Cordoba: Early progression beyond first-line chemoimmunotherapy in follicular lymphoma by Alberto Bavieri et al.
Dec 30, 2024, 10:54

Raul Cordoba: Early progression beyond first-line chemoimmunotherapy in follicular lymphoma by Alberto Bavieri et al.

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit, shared a post on X:

“Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study – Bavieri – 2024.”

Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study

Authors: Alberto Bavieri et al.

Raul cordoba

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation.

He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.

Alberto Bavieri Alessandra Tucci Alessia Bari Annalisa Arcari Antonella Anastasia Antonino Neri Benedetta Bianchi Clara Mannarella Federica Cavallo Fortunato Morabito Gloria M. Casaluci Jacopo Olivieri Maggi Alessandro Mansueto G. Rosaria Maria E. Nizzoli Massimo Gentile Michele Cimminiello Nicola Di Renzo Ombretta Annibali Stefano Luminari Vicenzo Pavone Vittoria Tarantino Vittorio R. Zilioli
Special Coverage
Insight
Dec 30, 2024, 10:54
Raul Cordoba: Early progression beyond first-line chemoimmunotherapy in follicular lymphoma by Alberto Bavieri et al.
Blog
Dec 30, 2024, 10:51
A massive turnout for the free cancer screening event by NCI of Kenya and Bongaa Health Foundation - NCI of Kenya
Blog
Dec 30, 2024, 10:48
Rahul Banerjee: Fascinating work by Noopur Raje et al looking at visceral EMD in Multiple Myeloma
Blog
Dec 30, 2024, 10:45
The report of "Girem Full!" 2024: The power of books to fight cancer - IDIBAPS
Blog
Dec 30, 2024, 10:05
Translational genomics and targeted therapies in solid tumours - August Pi i Sunyer Biomedical Research Institute
Science
Dec 30, 2024, 08:49
Alessio Cortellini: Strength lies in collaboration
Science
Dec 30, 2024, 08:35
Are PPIs beneficial or harmful for stress ulcer prophylaxis in mechanically ventilated patients? - NEJM Group
Blog
Dec 30, 2024, 07:41
Antonio M. Grimaldi: Next Generation Sequencing diagnostics will soon be available at San Giovanni Addolorata Hospital, Benevento
Blog
Dec 30, 2024, 07:37
Douglas Flora: Deeply inspired by the progress made at St. Elizabeth Healthcare
Blog
Dec 30, 2024, 07:34
National Center for Cancer Immune Therapy of Denmark at ESMO Immuno-Oncology Congress 2024
Blog
Dec 30, 2024, 07:29
Don't let holiday stress steal your joy - St. Elizabeth Healthcare
Insight
Dec 30, 2024, 07:26
Self-referral for lung cancer tests would be a step in the right direction